By Tarun Sai Lomte New research explores how attention difficulties, sleep disruption, and cognitive control challenges ...

The findings, which were published in the Journal of Attention Disorders, coincide with a wave of awareness that adults can ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMSOUTH SAN FRANCISCO, Calif., ...

Myqorzo (aficamten) is a new therapy for oHCM, improving functional capacity and symptoms, with an annual cost of $108,400. The Myqorzo & You program provides personalized support, including insurance ...

Death cap mushroom poisonings in California have reached record levels. Many of those poisoned are immigrants.

Doctor warns Trump is displaying signs of cognitive decline, including memory issues, inattention, and rambling speech that ...

Each Olympic cycle, athletes and support staff chase the latest cutting-edge knowledge in pursuit of Gold. In the Winter ...

After decades of misdiagnosis and missed signals, researchers are finally starting to close the gender gap that has long ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incor ...

Independent observational case series of LTR Pharma’s intranasal erectile dysfunction spray Spontan reports positive outcomes ...

Neurodegenerative diseases (NDs) are among the most urgent global health challenges, affecting millions worldwide and placing a growing burden on healthcare ...

According to DelveInsight's analysis, the primary sclerosing cholangitis market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as LB-P8 ...